Level and correlates of social support in a community‐based sample of Australians who primarily smoke methamphetamine

Few studies have examined panic attacks and social and demographic factors, amongst people who use methamphetamine. This study explores the prevalence and correlates of panic attacks amongst an Australian sample of 711 people who primarily smoke methamphetamine. Baseline data for this study was gathered from participants recruited from regional and metropolitan communities across Victoria, Australia, in an ongoing prospective cohort study. Sequential logistic regression was used to examine correlations between panic attacks and sociodemographic, mental health and methamphetamine use variables. Over one-third (36%) of participants reported experiencing a recent panic attack (within the last 4 weeks). The following characteristics were associated with an increased likelihood of panic attacks: being female [aOR 1.85, 95% CI 1.25, 2.60], younger (18–29 years) [aOR 1.82, 95% CI 1.16, 2.85], non-heterosexual [aOR 2.19, 95% CI 1.37, 3.49], having experienced interpersonal assault in the past 12 months [aOR 1.71, 95% CI 1.19, 2.45], being methamphetamine-dependent [aOR 1.78, 95% CI 1.22, 2.59] and reporting moderate to severe symptoms of anxiety [aOR 5.49, 95% CI 3.93, 7.69] and depression [aOR 3.98, 95% CI 2.86, 5.53]. Opportunities exist for health services to proactively engage and support this population when they present in distressed states, with a non-judgemental, trauma-informed approach. Highlights • It is estimated that over one third of people who smoke methamphetamine experience panic attacks. • Methamphetamine smokers who are young, female and non-heterosexual are at increased risk of experiencing panic attacks. • Presentations during mental distress are an opportunity for psychoeducation and harm reduction discussions.

show abstract

Prevalence and Correlates of Panic Attacks Among People Who Primarily Smoke Methamphetamine

Hine

Ward

Kippen

et al. 2023

Int J Ment Health Addiction

View full text Add to dashboard Cite

show abstract

Anxiety and depression among a community‐recruited cohort of people who use methamphetamine: A longitudinal analysis

Duncan,

Kippen,

Sutton

et al. 2024

Addiction

View full text Add to dashboard Cite

AimsThis study (1) estimated changes in anxiety and depression throughout 3 years in a community‐recruited cohort who use methamphetamine and (2) modelled whether these changes were associated with patterns of methamphetamine use or other time‐varying or fixed covariates.Design, setting and participantsWe used a longitudinal analysis using data derived from surveys conducted between August 2016 and March 2020, set in metropolitan and rural locations in Victoria, Australia. Participants comprised a total of 849 adults with regular methamphetamine use history at baseline, recruited for the prospective VMAX study via snowball and respondent‐driven sampling.MeasurementsAnxiety and depression symptoms were measured using the Generalized Anxiety Disorder (GAD)‐7 and the Patient Health Questionnaire (PHQ)‐9 instruments. Frequency of methamphetamine use was measured by self‐reported number of days per week participants used any form of methamphetamine in the past month.FindingsChanges in anxiety and depression symptom scores were associated with change in route of administration from non‐injecting to injecting [adjusted coefficient (adj. coeff.) = 1.44, 95% confidence intervals (CI) = 0.39, 2.48, adj. coeff. = 1.49, 95% CI = 0.39, 2.58], change in severity of dependence for methamphetamine (adj. coeff. = 0.29, 95% CI = 0.21, 0.37, adj. coeff. = 0.34, 95% CI = 0.26, 0.42), starting treatment for drugs other than methamphetamine (adj. coeff. = −2.21, 95% CI = −3.70, −0.73, adj. coeff. = −2.09, 95% CI = −3.60, −0.58) and other covariates.ConclusionsAmong regular methamphetamine users in Australia, changes in anxiety or depression scores are associated with changes in route of administration, dependence severity and starting treatment for other drugs, but do not appear to be associated with frequency of methamphetamine use.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Level and correlates of social support in a community‐based sample of Australians who primarily smoke methamphetamine

Cited by 2 publications

References 45 publications

Prevalence and Correlates of Panic Attacks Among People Who Primarily Smoke Methamphetamine

Prevalence and Correlates of Panic Attacks Among People Who Primarily Smoke Methamphetamine

Anxiety and depression among a community‐recruited cohort of people who use methamphetamine: A longitudinal analysis

Contact Info

Product

Resources

About